InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-10-31 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-10-30 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2025-09-23 | Valerie Hoyle(D-OR04) | house | Sale | $1,001 - $15,000 |
| 2025-08-19 | Kelly Louise Morrison(D-MN03) | house | Sale | $15,001 - $50,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenues | — | — | — | — | $8.85B |
| Total revenues | $18.59B+4.2% | $17.84B+1.3% | $17.61B+7.6% | $16.37B | — |
| Selling, general and administrative expenses | $8.73B+1.6% | $8.60B+1.8% | $8.45B-6.1% | $8.99B+12.3% | $8.01B |
| Research and development expenses | $1.40B+0.5% | $1.39B+4.0% | $1.34B-9.1% | $1.47B+4.6% | $1.41B |
| Restructuring and other costs | $362.0M-4.5% | $379.0M-17.4% | $459.0M+302.6% | $114.0M-42.1% | $197.0M |
| Total costs and operating expenses | $36.81B+3.6% | $35.54B-1.3% | $36.00B-1.4% | $36.52B+25.1% | $29.18B |
| Operating income | $7.75B+5.6% | $7.34B+7.0% | $6.86B-18.3% | $8.39B-16.3% | $10.03B |
| Interest income | $993.0M-7.9% | $1.08B+22.6% | $879.0M+223.2% | $272.0M+532.6% | $43.0M |
| Interest expense | -$1.42B-2.1% | -$1.39B-1.1% | -$1.38B-89.4% | -$726.0M-35.4% | -$536.0M |
| Other income/(expense) | -$12.0M-200.0% | $12.0M+118.5% | -$65.0M+37.5% | -$104.0M+85.0% | -$694.0M |
| Income before income taxes | $7.31B+3.9% | $7.04B+11.7% | $6.30B-19.6% | $7.83B-11.4% | $8.84B |
| Benefit from/(provision for) income taxes | -$547.0M+16.7% | -$657.0M-131.3% | -$284.0M+59.6% | -$703.0M | — |
| Equity in earnings/(losses) of unconsolidated entities | -$41.0M+2.4% | -$42.0M+28.8% | -$59.0M+65.7% | -$172.0M-4200.0% | -$4.0M |
| Net income | $6.72B+6.0% | $6.34B+6.4% | $5.96B-14.4% | $6.96B-9.9% | $7.73B |
| Less: net income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest | $17.0M+466.7% | $3.0M+107.5% | -$40.0M | — | — |
| Net income attributable to Thermo Fisher Scientific Inc. | $6.70B+5.8% | $6.33B+5.7% | $6.00B-13.7% | $6.95B-10.0% | $7.72B |
| Basic (in dollars per share) | $17.8M+7.2% | $16.6M+6.8% | $15.5M-12.6% | $17.8M-9.5% | $19.6M |
| Diluted (in dollars per share) | $17.7M+7.3% | $16.5M+7.0% | $15.4M-12.4% | $17.6M-9.4% | $19.5M |
| Basic (in shares) | $377.0M-1.3% | $382.0M-1.0% | $386.0M-1.5% | $392.0M-0.5% | $394.0M |
| Diluted (in shares) | $378.0M-1.3% | $383.0M-1.3% | $388.0M-1.5% | $394.0M-0.8% | $397.0M |
| Product revenues | |||||
| Revenues | — | — | — | — | $8.85B |
| Total revenues | $18.59B+4.2% | $17.84B+1.3% | $17.61B+7.6% | $16.37B | — |
| Cost of revenues | $12.91B+2.0% | $12.65B+0.5% | $12.59B+7.6% | $11.70B+95.6% | $5.98B |
| Service revenues | |||||
| Revenues | — | — | — | — | $8.85B |
| Total revenues | $18.59B+4.2% | $17.84B+1.3% | $17.61B+7.6% | $16.37B | — |
| Cost of revenues | $12.91B+2.0% | $12.65B+0.5% | $12.59B+7.6% | $11.70B+95.6% | $5.98B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Top 25 High-Growth Dividend Stocks For May 2026
Billionaire Investor Takes New Stake In Thermo Fisher Scientific
How Investors Are Reacting To Thermo Fisher Scientific (TMO) Expanding Its U.S. Bioprocess Design Center
Is Corning Stock A Buy At 50 Times Earnings?